CHRISTOPHER J COUGHLIN
CIK 1110750 · EVP and CFO · last filed 2026-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.06M
Companies
12
Total Filings
200
Lifetime Open-Market Net
$2.09M
Filer Profile
Related Filers
Actavis plc — 19 joint filings, latest 2020-05-11
ALEXION PHARMACEUTICALS, INC. — 13 joint filings, latest 2021-07-23
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CNC | Director | 48,764 | $67.04 | $3.27M | $0 | 2 | 2026-07-01 |
| CNTE | Director | 48,202 | — | — | $1.50M | 25 | 2026-05-13 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | Director | 0 | $329.83 | $0 | $0 | 6 | 2024-03-18 |
| PBH | Director | 13,218 | $52.26 | $690.8K | $0 | 4 | 2022-08-03 |
| Allergan plc (AGN) Delisted | Director | 16,542 | — | — | $3.54M | 14 | 2020-05-11 |
| DUN & BRADSTREET CORP/NW (DNB) Delisted | Director | 17,335 | $9.15 | $158.6K | -$740.5K | 76 | 2017-03-13 |
| HOLOGIC INC (HOLX) Delisted | Director | 5,427 | $76.01 | $412.5K | $0 | 2 | 2017-03-09 |
| ACT | Director | 2,000 | $49.27 | $98.5K | $0 | 1 | 2015-06-08 |
| Covidien plc (COV) Delisted | Director | 58,032 | — | — | -$2.23M | 36 | 2014-03-21 |
| PLx Pharma Inc. (DPRX) Delisted | Director | 13,664 | — | — | $25.0K | 1 | 2014-03-20 |
| Forest Laboratories, LLC (FRX) Delisted | Director | 3,933 | $12.00 | $47.2K | $0 | 3 | 2013-08-16 |
| Johnson Controls International plc (TYC) Delisted | EVP and CFO | 84,573 | — | — | $0 | 7 | 2010-11-30 |
Recent Filings · Page 13 of 20
200 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-06-15 | DUN & BRADSTREET CORP/NW (DNB) Delisted | Grant (A) | +58 | $3.9K | EDGAR |
| 2012-05-11 | DUN & BRADSTREET CORP/NW (DNB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-05-09 | Covidien plc (COV) Delisted | Grant (A) | +11 | $597 | EDGAR |
| 2012-03-16 | DUN & BRADSTREET CORP/NW (DNB) Delisted | Grant (A) | +45 | $3.9K | EDGAR |
| 2012-03-14 | Covidien plc (COV) Delisted | Mixed | +1,658 | -$55.7K | EDGAR |
| 2012-03-05 | DUN & BRADSTREET CORP/NW (DNB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-02-24 | Covidien plc (COV) Delisted | Grant (A) | +11 | $577 | EDGAR |
| 2012-02-15 | DUN & BRADSTREET CORP/NW (DNB) Delisted | Grant (A) | +1,517 | $120.0K | EDGAR |
| 2011-12-15 | DUN & BRADSTREET CORP/NW (DNB) Delisted | Grant (A) | +44 | $3.1K | EDGAR |
| 2011-11-08 | Covidien plc (COV) Delisted | Grant (A) | +14 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.